Selected research
Industry Research
Cisplatin Injection Industry Research Report 2026
Market perspective
The global Cisplatin Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cisplatin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cisplatin Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cisplatin Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cisplatin Injection include Cipla, Hospira(Pfizer), Taj Pharmaceuticals, Fresenius Kabi, Lingnan Pharmacy, Hansoh Pharma, Jinzhou Jiutai Pharmaceutical, Nanjing Pharmaceutical Factory and Qilu Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cisplatin Injection market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cisplatin Injection Market by Company
Cipla
Hospira(Pfizer)
Taj Pharmaceuticals
Fresenius Kabi
Lingnan Pharmacy
Hansoh Pharma
Jinzhou Jiutai Pharmaceutical
Nanjing Pharmaceutical Factory
Qilu Pharmaceutical
Luoxin
Teva
Bievalley
Yunnan Phytopharmaceutical
Cisplatin Injection Segment by Type
50ml
100ml
200ml
Cisplatin Injection Segment by Application
NSCLC
Testicular Cancer
Ovarian Cancer
Other
Cisplatin Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cisplatin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cisplatin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cisplatin Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cisplatin Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cisplatin Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cisplatin Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 50ml
- 100ml
- 200ml
Applications
- NSCLC
- Testicular Cancer
- Ovarian Cancer
- Other
Companies covered
- Cipla
- Hospira(Pfizer)
- Taj Pharmaceuticals
- Fresenius Kabi
- Lingnan Pharmacy
- Hansoh Pharma
- Jinzhou Jiutai Pharmaceutical
- Nanjing Pharmaceutical Factory
- Qilu Pharmaceutical
- Luoxin
- Teva
- Bievalley
- Yunnan Phytopharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cisplatin Injection Market Size (2021-2032)
- 2.2.2 Global Cisplatin Injection Sales (2021-2032)
- 2.2.3 Global Cisplatin Injection Market Average Price (2021-2032)
- 2.3 Cisplatin Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 50ml
- 2.3.3 100ml
- 2.3.4 200ml
- 2.4 Cisplatin Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 NSCLC
- 2.4.3 Testicular Cancer
- 2.4.4 Ovarian Cancer
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cisplatin Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cisplatin Injection Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Cisplatin Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Cisplatin Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Cisplatin Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cisplatin Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cisplatin Injection, Product Type & Application
- 3.8 Global Manufacturers of Cisplatin Injection, Established Date
- 3.9 Global Cisplatin Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Cipla
- 4.1.1 Cipla Company Information
- 4.1.2 Cipla Business Overview
- 4.1.3 Cipla Cisplatin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Cipla Cisplatin Injection Product Portfolio
- 4.1.5 Cipla Recent Developments
- 4.2 Hospira(Pfizer)
- 4.2.1 Hospira(Pfizer) Company Information
- 4.2.2 Hospira(Pfizer) Business Overview
- 4.2.3 Hospira(Pfizer) Cisplatin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Hospira(Pfizer) Cisplatin Injection Product Portfolio
- 4.2.5 Hospira(Pfizer) Recent Developments
- 4.3 Taj Pharmaceuticals
- 4.3.1 Taj Pharmaceuticals Company Information
- 4.3.2 Taj Pharmaceuticals Business Overview
- 4.3.3 Taj Pharmaceuticals Cisplatin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Taj Pharmaceuticals Cisplatin Injection Product Portfolio
- 4.3.5 Taj Pharmaceuticals Recent Developments
- 4.4 Fresenius Kabi
- 4.4.1 Fresenius Kabi Company Information
- 4.4.2 Fresenius Kabi Business Overview
- 4.4.3 Fresenius Kabi Cisplatin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Fresenius Kabi Cisplatin Injection Product Portfolio
- 4.4.5 Fresenius Kabi Recent Developments
- 4.5 Lingnan Pharmacy
- 4.5.1 Lingnan Pharmacy Company Information
- 4.5.2 Lingnan Pharmacy Business Overview
- 4.5.3 Lingnan Pharmacy Cisplatin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Lingnan Pharmacy Cisplatin Injection Product Portfolio
- 4.5.5 Lingnan Pharmacy Recent Developments
- 4.6 Hansoh Pharma
- 4.6.1 Hansoh Pharma Company Information
- 4.6.2 Hansoh Pharma Business Overview
- 4.6.3 Hansoh Pharma Cisplatin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Hansoh Pharma Cisplatin Injection Product Portfolio
- 4.6.5 Hansoh Pharma Recent Developments
- 4.7 Jinzhou Jiutai Pharmaceutical
- 4.7.1 Jinzhou Jiutai Pharmaceutical Company Information
- 4.7.2 Jinzhou Jiutai Pharmaceutical Business Overview
- 4.7.3 Jinzhou Jiutai Pharmaceutical Cisplatin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Jinzhou Jiutai Pharmaceutical Cisplatin Injection Product Portfolio
- 4.7.5 Jinzhou Jiutai Pharmaceutical Recent Developments
- 4.8 Nanjing Pharmaceutical Factory
- 4.8.1 Nanjing Pharmaceutical Factory Company Information
- 4.8.2 Nanjing Pharmaceutical Factory Business Overview
- 4.8.3 Nanjing Pharmaceutical Factory Cisplatin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Nanjing Pharmaceutical Factory Cisplatin Injection Product Portfolio
- 4.8.5 Nanjing Pharmaceutical Factory Recent Developments
- 4.9 Qilu Pharmaceutical
- 4.9.1 Qilu Pharmaceutical Company Information
- 4.9.2 Qilu Pharmaceutical Business Overview
- 4.9.3 Qilu Pharmaceutical Cisplatin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Qilu Pharmaceutical Cisplatin Injection Product Portfolio
- 4.9.5 Qilu Pharmaceutical Recent Developments
- 4.10 Luoxin
- 4.10.1 Luoxin Company Information
- 4.10.2 Luoxin Business Overview
- 4.10.3 Luoxin Cisplatin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Luoxin Cisplatin Injection Product Portfolio
- 4.10.5 Luoxin Recent Developments
- 4.11 Teva
- 4.11.1 Teva Company Information
- 4.11.2 Teva Business Overview
- 4.11.3 Teva Cisplatin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Teva Cisplatin Injection Product Portfolio
- 4.11.5 Teva Recent Developments
- 4.12 Bievalley
- 4.12.1 Bievalley Company Information
- 4.12.2 Bievalley Business Overview
- 4.12.3 Bievalley Cisplatin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Bievalley Cisplatin Injection Product Portfolio
- 4.12.5 Bievalley Recent Developments
- 4.13 Yunnan Phytopharmaceutical
- 4.13.1 Yunnan Phytopharmaceutical Company Information
- 4.13.2 Yunnan Phytopharmaceutical Business Overview
- 4.13.3 Yunnan Phytopharmaceutical Cisplatin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Yunnan Phytopharmaceutical Cisplatin Injection Product Portfolio
- 4.13.5 Yunnan Phytopharmaceutical Recent Developments
5 Global Cisplatin Injection Market Scenario by Region
- 5.1 Global Cisplatin Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cisplatin Injection Sales by Region: 2021-2032
- 5.2.1 Global Cisplatin Injection Sales by Region: 2021-2026
- 5.2.2 Global Cisplatin Injection Sales by Region: 2027-2032
- 5.3 Global Cisplatin Injection Revenue by Region: 2021-2032
- 5.3.1 Global Cisplatin Injection Revenue by Region: 2021-2026
- 5.3.2 Global Cisplatin Injection Revenue by Region: 2027-2032
- 5.4 North America Cisplatin Injection Market Facts & Figures by Country
- 5.4.1 North America Cisplatin Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cisplatin Injection Sales by Country (2021-2032)
- 5.4.3 North America Cisplatin Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Cisplatin Injection Market Facts & Figures by Country
- 5.5.1 Europe Cisplatin Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cisplatin Injection Sales by Country (2021-2032)
- 5.5.3 Europe Cisplatin Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Cisplatin Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cisplatin Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cisplatin Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cisplatin Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cisplatin Injection Market Facts & Figures by Country
- 5.7.1 South America Cisplatin Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cisplatin Injection Sales by Country (2021-2032)
- 5.7.3 South America Cisplatin Injection Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Cisplatin Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cisplatin Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cisplatin Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cisplatin Injection Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Cisplatin Injection Sales by Type (2021-2032)
- 6.1.1 Global Cisplatin Injection Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Cisplatin Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Cisplatin Injection Revenue by Type (2021-2032)
- 6.2.1 Global Cisplatin Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cisplatin Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Cisplatin Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cisplatin Injection Sales by Application (2021-2032)
- 7.1.1 Global Cisplatin Injection Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Cisplatin Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Cisplatin Injection Revenue by Application (2021-2032)
- 7.2.1 Global Cisplatin Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cisplatin Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Cisplatin Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cisplatin Injection Value Chain Analysis
- 8.1.1 Cisplatin Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cisplatin Injection Production Mode & Process
- 8.2 Cisplatin Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cisplatin Injection Distributors
- 8.2.3 Cisplatin Injection Customers
9 Global Cisplatin Injection Analyzing Market Dynamics
- 9.1 Cisplatin Injection Industry Trends
- 9.2 Cisplatin Injection Industry Drivers
- 9.3 Cisplatin Injection Industry Opportunities and Challenges
- 9.4 Cisplatin Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst